5.1 Hemodialysis Clinical Assessment & Vascular Access Considerations

Hemodialysis Clinical Assessment & Vascular Access Considerations

Maintenance hemodialysis (HD) replaces defective renal excretory and regulatory functions through extracorporeal blood purification. For the renal nutrition specialist, clinical assessment extends far beyond tracking dietary recall; it requires a granular understanding of dialyzer biophysics, dialysate bath chemistry, and vascular access integrity. The hemodialysis prescription directly shapes the patient's nutritional requirements, electrolyte balance, systemic inflammatory tone, and voluntary caloric intake.

---

Hemodialysis Solute & Fluid Transport Biophysics

Mass transfer across the semipermeable hollow-fiber dialyzer membrane relies on three distinct physical transport mechanisms:

┌────────────────────────────────────────────────────────────────────────┐
│                     Hemodialysis Transport Principles                  │
├────────────────────────────────────────────────────────────────────────┤
│  1. Diffusion (Concentration Gradient Driven)                          │
│  • Random thermal motion of solute molecules down a chemical gradient. │
│  • Governs clearance of small water-soluble molecules: urea (60 Da),   │
│    creatinine (113 Da), potassium, and phosphate.                      │
│  • Maximized by countercurrent blood and dialysate flow.               │
│                                                                        │
│  2. Convection (Solvent Drag Driven)                                   │
│  • Solute drag caused by bulk hydrostatic fluid flux across membrane.  │
│  • Driven by Transmembrane Pressure (TMP = P_blood - P_dialysate).     │
│  • Primary mechanism for clearance of middle molecules:               │
│    beta-2 microglobulin (11.8 kDa) and inflammatory cytokines.         │
│                                                                        │
│  3. Ultrafiltration (Hydrostatic Water Movement)                       │
│  • Direct extraction of plasma water across dialyzer hollow fibers.    │
│  • Safe Ultrafiltration Rate (UFR) threshold: < 10–13 mL/kg/hour.      │
│  • Excessive UFR triggers myocardial stunning and gut ischemia.        │
└────────────────────────────────────────────────────────────────────────┘

Diffusion

Diffusion is the primary mechanism for clearing small nitrogenous waste products. The rate of diffusion ($J_d$) is proportional to the concentration gradient between blood and dialysate ($C_b - C_d$), the dialyzer surface area, membrane permeability, and solute temperature, while inversely proportional to solute molecular weight and membrane thickness. Blood flow ($Q_b$, typically 350–500 mL/min) and dialysate flow ($Q_d$, typically 500–800 mL/min) are oriented in a countercurrent direction to maintain a persistent concentration gradient along the entire length of the dialyzer fibers.

Convection and Solvent Drag

Convection occurs when water is driven across the membrane by a hydrostatic pressure gradient (Transmembrane Pressure, TMP), dragging dissolved solutes along with it. Convective clearance is independent of solute concentration gradients and is primarily governed by the membrane's ultrafiltration coefficient ($K_{uf}$) and pore size distribution. Modern high-flux synthetic membranes (e.g., polysulfone, polyethersulfone) possess larger pore radii that optimize convective clearance of middle-molecule uremic toxins such as $\beta_2$-microglobulin (11,818 Da), advanced glycation end-products (AGEs), and circulating inflammatory peptides.

Ultrafiltration (UF) and Nutritional Thresholds

Ultrafiltration is the physical removal of plasma water across the dialyzer membrane. The Ultrafiltration Rate (UFR) is quantified in milliliters per kilogram of dry weight per hour (mL/kg/h). Aggressive ultrafiltration designed to remove large interdialytic weight gains (IDWG $> 5\%$ of dry weight) within short treatment times (3.5–4.0 hours) frequently yields a UFR exceeding $13$ mL/kg/h.

Clinical Hazard: UFRs $> 13$ mL/kg/h induce transient recurrent myocardial stunning, splanchnic hypoperfusion, endotoxin translocation from the gut lumen into the bloodstream, and profound post-dialysis exhaustion. Splanchnic ischemia causes nausea, postprandial distress, and progressive uremic anorexia, severely accelerating muscle wasting.

---

Dialysate Composition & Prescription Titration

Dialysate is an aqueous solution prepared online by mixing purified water with concentrated acid and bicarbonate solutions. The clinical dietitian must actively review the monthly dialysate bath prescription, as electrolyte configurations dictate systemic metabolic parameters.

The Sodium Modeling Dilemma

To prevent intradialytic hypotension and cramping, nephrologists historically utilized sodium modeling (sodium profiling), beginning treatment with a hypertonic dialysate sodium bath (e.g., 145–148 mEq/L) and stepping down to 138 mEq/L by treatment end.

Mechanism of Failure: Because the dialysate sodium concentration during the initial hours exceeds plasma sodium, sodium diffuses from dialysate into the patient's bloodstream. This positive sodium balance elevates extracellular osmolality, stimulating hypothalamic osmoreceptors. Patients experience intractable, overwhelming thirst post-treatment, drinking massive quantities of fluid to restore tonicity. Sodium modeling directly drives excessive IDWG, volume-dependent hypertension, and left ventricular hypertrophy (LVH). Modern practice advocates aligning dialysate sodium with the patient's mean pre-dialysis plasma sodium (isovolemic sodium prescription, typically 137–138 mEq/L).

Potassium Bath Selection & Arrhythmogenesis

Dialysate potassium baths are typically formulated at 1.0 mEq/L (1K), 2.0 mEq/L (2K), or 3.0 mEq/L (3K). A common clinical error is reflexively ordering a 1K bath for patients presenting with pre-dialysis hyperkalemia ($K^+ > 6.0$ mEq/L). Rapid clearance across a steep blood-to-dialysate potassium gradient induces sudden shifts in extracellular potassium, altering the resting membrane potential of cardiomyocytes and precipitating QT prolongation, ventricular tachycardia, and sudden cardiac death—particularly in patients receiving digitalis or with underlying ischemic cardiomyopathy. A 2K or 3K bath paired with targeted dietary counseling and non-absorbed potassium binders (e.g., patiromer, sodium zirconium cyclosilicate) is substantially safer.

---

Vascular Access Types & Nutritional Sequelae

A functioning vascular access is the patient's lifeline. The choice of access directly impacts systemic inflammation, cardiovascular workload, and protein metabolism.

┌────────────────────────────────────────────────────────────────────────┐
│                     Vascular Access Hierarchy                          │
├────────────────────────────────────────────────────────────────────────┤
│  1. Arteriovenous Fistula (AVF) — Gold Standard                        │
│  • Surgical anastomosis of native vein to artery (e.g., radiocephalic). │
│  • Lowest thrombosis and infection rates of any access type.           │
│  • Negligible systemic inflammation; preserves serum albumin.          │
│                                                                        │
│  2. Arteriovenous Graft (AVG)                                          │
│  • Synthetic polytetrafluoroethylene (PTFE) prosthetic conduit.        │
│  • Intermediate infection risk; higher thrombosis rate than an AVF.    │
│  • Mild inflammatory tone; pseudointimal hyperplasia at venous outlet. │
│                                                                        │
│  3. Tunneled Cuffed Central Venous Catheter (CVC)                      │
│  • Polyurethane conduit inserted into internal jugular / right atrium. │
│  • Highest infection and bacteremia risk of any access type.           │
│  • Induces high-grade systemic inflammation (CRP, IL-6 surge).         │
│  • Drives ubiquitin-proteasome pathway, severe PEW, and anorexia.      │
└────────────────────────────────────────────────────────────────────────┘

The CVC-Systemic Inflammation-PEW Axis

Tunneled central venous catheters provoke continuous biological trauma. Mechanical friction of the catheter tip against the endothelial lining of the superior vena cava and right atrium induces microvascular thrombi. Concurrently, bacterial colonization establishes intraluminal biofilms that release endotoxins into the circulation, even in the absence of overt bacteremia or fever.

This subclinical inflammatory nidus stimulates monocytes and macrophages to release high concentrations of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-$\alpha$), and interleukin-1 beta (IL-1$\beta$). These cytokines elicit devastating nutritional consequences:

1. Hepatic Reprogramming: Cytokines signal hepatocytes to downregulate albumin, prealbumin, and transferrin transcription (negative acute-phase reactants) while upregulating C-reactive protein (CRP), serum amyloid A, and fibrinogen. Consequently, hypoalbuminemia ($< 3.5$ g/dL) in catheter-dependent patients reflects inflammatory suppression rather than simple dietary protein deficiency.
2. Hypothalamic Anorexia: Circulating IL-6 and TNF-$\alpha$ cross the blood-brain barrier, altering neuropeptide Y (NPY) and pro-opiomelanocortin (POMC) signaling in the arcuate nucleus, causing persistent anorexia, early satiety, and food aversion.
3. Ubiquitin-Proteasome Skeletal Proteolysis: Inflammatory cytokines activate the ATP-dependent ubiquitin-proteasome proteolytic cascade in skeletal muscle, tagging myofibrillar proteins (actin and myosin) for enzymatic degradation. Catheter-dependent patients experience rapid, progressive loss of lean muscle mass, temporal wasting, and accelerated Protein-Energy Wasting (PEW).

---

Access Surveillance, Recirculation & Delivered Dialysis Adequacy

Delivered dialysis dose is routinely quantified by single-pool $Kt/V$ ($spKt/V$, clinical target $\ge 1.4$; minimum per CMS Conditions for Coverage $\ge 1.2$) and urea reduction ratio (URR $\ge 65\%$). Access dysfunction severely impairs delivered clearance.

Access Flow ($Q_a$) Surveillance

Healthy native AVFs maintain access blood flow ($Q_a$) between 600 and 1,200 mL/min, whereas AVGs maintain $Q_a$ between 800 and 1,500 mL/min. Venous anastomotic neointimal hyperplasia narrows the vascular lumen, decreasing $Q_a$. When $Q_a$ drops below 500 mL/min in an AVF or 600 mL/min in an AVG, access thrombosis is imminent.

Access Recirculation

When access blood flow ($Q_a$) falls below the extracorporeal blood pump flow ($Q_b$), or when needle placement is reversed or spaced too closely ($< 5$ cm apart), access recirculation occurs. Dialyzed, urea-depleted blood returning via the venous needle is immediately drawn back into the arterial needle. Recirculation dilutes the entering solute concentration, severely depressing the concentration gradient across the dialyzer membrane.

$\text{Recirculation Fraction (\%)} = \frac{C_p - C_a}{C_p - C_v} \times 100$

(where $C_p$ is systemic peripheral blood urea, $C_a$ is arterial line blood urea, and $C_v$ is venous line blood urea).

Recirculation above about 10% (two-needle urea method) warrants access evaluation because it lowers delivered $spKt/V$. Uremic retention solutes—including middle molecules, protein-bound indoxyl sulfate, and p-cresyl sulfate—accumulate rapidly. Patients develop severe uremic dysgeusia (metallic taste), central nausea, peripheral neuropathy, and profound anorexia. The clinical dietitian must recognize that involuntary weight loss and falling nPNA in an access-compromised patient stems from structural underdialysis rather than primary behavioral dietary non-adherence.